Premium
P1‐022: The use of AlphaLISA in measurement of Aβ1–15/16 as a potential biomarker in neurodegenerative diseases
Author(s) -
Nutu Magdalena,
Bourgeois Philippe,
Zetterberg Henrik,
Portelius Erik,
Lipari Francesco,
Parent Stéphane,
Hansson Oskar,
Blennow Kaj
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.297
Subject(s) - progressive supranuclear palsy , corticobasal degeneration , dementia with lewy bodies , biomarker , cerebrospinal fluid , dementia , atrophy , medicine , pathology , immunoassay , chemistry , disease , immunology , antibody , biochemistry
Magdalena Nutu, Philippe Bourgeois, Henrik Zetterberg, Erik Portelius, Francesco Lipari, St ephane Parent, Oskar Hansson, Kaj Blennow, The Sahlgrenska Academy, Gothenburg, Sweden; PerkinElmer Biosignal, Inc, Montreal, Quebec, Canada; University of Gothenburg, M€olndal, Sweden; Institute of Neuroscience and Physiology, M€olndal, Sweden; PerkinElmer Inc, Montreal, Quebec, Canada; Depatment of Neurology, Sk ane University Hospital, Malm€o, Sweden; Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, M€olndal, Sweden.